News UK women's health firm Theramex sold for around £2.2bn Theramex, a UK-based specialty pharma company focusing on women's health, is changing hands in a private equity deal said to be worth around £2.2bn.
News Resistance grows to Recordati's private equity takeover The offer for Recordati by private equity firms CVC and GBL undervalues the company and is unfair to minority shareholders, claims activist investor.
Sales & Marketing M&A trends in diagnostics and life sciences tools The diagnostics and life sciences tools sector is attracting continued investor interest across both private equity and large corporates.
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
News Blackstone closes record $6.3bn life sciences fund Blackstone has closed its latest fund – the $6.3bn BXLS VI – saying it is the largest ever private fund for the life sciences sector.
News Oxford BioMedica confirms private equity takeover talks Oxford BioMedica confirmed this morning that it has received an unsolicited approach from private equity group EQT about a possible takeover.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.